<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-41931" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Tricuspid Valve Endocarditis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Iftikhar</surname>
            <given-names>Syed F.</given-names>
          </name>
          <aff>UC Riverside/Riverside Community Hospt.</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmad</surname>
            <given-names>Faran</given-names>
          </name>
          <aff>Creighton University Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Syed Iftikhar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faran Ahmad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-41931.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tricuspid valve infective endocarditis is uncommon compared to left-sided infective endocarditis. Right-sided infected infective endocarditis accounts for approximately 5 to 10 percent of all cases of infective endocarditis (IE). The overwhelming majority of cases of right-sided infective endocarditis involve the tricuspid valve and the majority of tricuspid valve infective endocarditis is associated with intravenous drug use. With the rise of intravenous drug use in the United States, rates of tricuspid valve infective endocarditis have increased significantly since 2006. In addition to intravenous drug users, patients with hemodialysis catheters, pacemakers, and defibrillator leads are also at increased risk for tricuspid valve infective endocarditis. This activity reviews the evaluation and management of tricuspid valve endocarditis and highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance outcomes for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the causes of tricuspid valve endocarditis.</p></list-item><list-item><p>Describe the presentation of tricuspid valve endocarditis.</p></list-item><list-item><p>Summarize the treatment options for tricuspid valve endocarditis.</p></list-item><list-item><p>Explain the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by tricuspid valve endocarditis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=41931&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=41931">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-41931.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Tricuspid valve infective endocarditis (TVIE) is an uncommon entity, especially when compared to left-sided infective endocarditis. Right-sided infected infective endocarditis (RSIE) accounts for approximately 5 &#x02013; 10% of all cases of infective endocarditis (IE). <xref ref-type="bibr" rid="article-41931.r1">[1]</xref>&#x000a0;The overwhelming number of cases of RSIE involve the tricuspid valve with some estimates as high as 90%. The majority of TVIE are associated with IV drug use (IVDU). Given the rise of IVDU in the United States, rates of TVIE have also increased significantly since 2006. <xref ref-type="bibr" rid="article-41931.r2">[2]</xref> Along with IVDU, hemodialysis catheters, pacemakers, and defibrillator leads are also risk factors. Staphylococcus aureus is the most common organism, which causes TVIE.&#x000a0; However, various skin flora, as well as various Staphylococcus and Streptococcus species can infect the tricuspid valve. Duke&#x02019;s Criteria is used to establish the diagnosis of TVIE. However, there are certain aspects of TVIE which can make it detection difficult. Such features include absent murmur, concurrent pneumonia, and less peripheral phenomena such as splinter hemorrhages. <xref ref-type="bibr" rid="article-41931.r3">[3]</xref> Regardless, TVIE is treatable and has favorable outcomes if detected and treated early in its course.&#x000a0; Although RSIE and TVIE are increasing in prevalence, antibiotics and surgical options remain a mainstay of successful treatment.</p>
      </sec>
      <sec id="article-41931.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Important risk factors for tricuspid valve infective endocarditis (TVIE) include:</p>
        <p>Intravenous drug users&#x000a0;(IVDU): Infections resulting from IVDU involve 30% to 40% of all TVIE&#x000a0;cases.&#x000a0;</p>
        <p>Cardiac implantable electronic device (CIED) Infection: TVIE&#x000a0;is considered device&#x000a0;related if there is evidence of valvular vegetation and tricuspid regurgitation in the presence of positive blood cultures.&#x000a0;</p>
        <p>Indwelling catheter: hemodialysis, parenteral nutrition, and chemotherapy requiring long term central venous access.&#x000a0;</p>
      </sec>
      <sec id="article-41931.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>It is certain that cases of right-sided infective endocarditis (RSIE) and TVIE are increasing. In one study, hospitalizations for IVDU related infective endocarditis increased 12-percent. <xref ref-type="bibr" rid="article-41931.r4">[4]</xref> IVDU accounts for 86% of TVIE. TVIE is more common among males, although the ratio is normalizing.&#x000a0; Over time, the population with TVIE has become younger, and more commonly white. <xref ref-type="bibr" rid="article-41931.r4">[4]</xref></p>
      </sec>
      <sec id="article-41931.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>History and physical exam are essential towards making an adequate diagnosis in cases of TVIE. Establishing diagnosis can be more difficult in these cases because presentation can often be subacute or present with absence of typical IE features. Peripheral phenomenon such as splinter hemorrhages is less common, as is a cardiac murmur. However, clinicians must always be aware of potential complications of this disease process that are manifested by the various embolic phenomenon. Characteristics, which should lead clinicians to consider TVIE, include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fever</p>
          </list-item>
          <list-item>
            <p>Chills</p>
          </list-item>
          <list-item>
            <p>Anorexia</p>
          </list-item>
          <list-item>
            <p>Weight loss</p>
          </list-item>
          <list-item>
            <p>Fatigue</p>
          </list-item>
          <list-item>
            <p>Malaise</p>
          </list-item>
          <list-item>
            <p>Arthralgia</p>
          </list-item>
          <list-item>
            <p>Dyspnea on exertion</p>
          </list-item>
          <list-item>
            <p>A cough</p>
          </list-item>
          <list-item>
            <p>Pleuritic pain</p>
          </list-item>
          <list-item>
            <p>Abdominal Pain</p>
          </list-item>
        </list>
        <p>
<bold>Physical Exam Findings</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tachypnea</p>
          </list-item>
          <list-item>
            <p>Hypotension</p>
          </list-item>
          <list-item>
            <p>Cardiac murmur</p>
          </list-item>
          <list-item>
            <p>Splenomegaly</p>
          </list-item>
          <list-item>
            <p>Splinter hemorrhages</p>
          </list-item>
          <list-item>
            <p>Petechiae</p>
          </list-item>
          <list-item>
            <p>Janeway lesions</p>
          </list-item>
          <list-item>
            <p>Osler nodes</p>
          </list-item>
          <list-item>
            <p>Roth spots</p>
          </list-item>
          <list-item>
            <p>Focal neurologic deficits</p>
          </list-item>
          <list-item>
            <p>Joint effusion</p>
          </list-item>
          <list-item>
            <p>Clubbing</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-41931.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis of TVIE is based upon the modified Duke Criteria. This criterion is widely used to diagnose TVIE like all other forms of IE. This criterion allows one to stratify infective endocarditis into a category of definite, possible, or rejected. Based on clinical criteria definite endocarditis is defined as two primary criteria, one major with three minor criteria, or five minor criteria. Possible endocarditis is measured by the presence of one major with two minor criteria, or with three minor criteria alone.&#x000a0; <xref ref-type="bibr" rid="article-41931.r5">[5]</xref> The criteria classes are as follows:</p>
        <p>
<bold>Major Criteria</bold>
</p>
        <p>Positive blood culture(any of the followings):</p>
        <list list-type="bullet">
          <list-item>
            <p>Two separate blood cultures with organisms known to cause infective endocarditis or</p>
          </list-item>
          <list-item>
            <p>Organism consistent with endocarditis from blood cultures obtained 12 hours apart or</p>
          </list-item>
          <list-item>
            <p>Positive culture for organisms that are common skin contaminant in 3 or the majority of&#x000a0;&#x02265;4 separate blood cultures (first and last sample drawn at least 1 hour apart) or</p>
          </list-item>
          <list-item>
            <p>Single positive blood culture of Coxiella burnetti</p>
          </list-item>
        </list>
        <p>Evidence of endocardial involvement (vegetation, abscess, new valvular regurgitation, dehiscence of a prosthetic valve)</p>
        <p>
<bold>Minor Criteria</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Fever &#x0003e; 38 degrees C (100.4 degrees F)</p>
          </list-item>
          <list-item>
            <p>Immunologic occurrence: Roth spots, Osler nodes, glomerulonephritis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Predisposing heart defect or IVDU</p>
          </list-item>
          <list-item>
            <p>Vascular phenomena: septic emboli, arterial emboli, conjunctival hemorrhages, splinter hemorrhages, Janeway lesions, mycotic aneurysm</p>
          </list-item>
          <list-item>
            <p>A positive blood culture that does not meet essential criteria.</p>
          </list-item>
        </list>
        <p>Routine laboratory values in IE are generally nonspecific. Basic workup should be done. Some abnormalities which may be found include leukocytosis, elevated ESR, elevated CRP, normocytic anemia, or urinalysis revealing hematuria, proteinuria, or pyuria. EKG may reveal conduction anomalies such as heart block. <xref ref-type="bibr" rid="article-41931.r6">[6]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Chest radiographs should be obtained to evaluate for septic emboli or infiltrate.</p>
          </list-item>
          <list-item>
            <p>CT scan of the abdomen is helpful to evaluate for metastatic emboli. Such emboli include splenic or renal infarcts. Clinicians should have a low threshold to locate these potential foci.</p>
          </list-item>
          <list-item>
            <p>Blood cultures should be obtained in all individuals with suspected TVIE. A minimum of three sets should be collected from different sites. [26341945]</p>
          </list-item>
          <list-item>
            <p>Echocardiography should be performed in all individuals with suspected TVIE. Transthoracic echocardiogram (TTE) is the first test that is done. TTE is very specific. Transesophageal echocardiography should be pursued if TTE is negative, but a high clinical suspicion for IE exists. TEE may also be used if significant valve regurgitation exists and needs to be further evaluated prior to surgery. <xref ref-type="bibr" rid="article-41931.r7">[7]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-41931.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Some individuals with TVIE may be candidates for shorter duration antibiotic regimens(no evidence of renal failure, the absence of extrapulmonary metastatic infections or simultaneous&#x000a0;left sided infection). The 2-week regimens are not used in patients with IE of the aortic or mitral valve, in patients with MRSA, or patients with complicated IE. <xref ref-type="bibr" rid="article-41931.r8">[8]</xref> Patients with TVIE should be started on an empiric antibiotic regimen once it is suspected.</p>
        <p>Initial empiric antibiotics should include coverage against the most common pathogens. Thus staphylococcus and streptococcus coverage are recommended. Vancomycin is used as an initial choice of antibiotic. These medicines should be tailored based upon blood cultures results. Once an organism has been specified, antibiotics regimen should typically be continued for six weeks from the date of first negative blood culture. Very limited patients can be trialed with a short duration course. These candidates include those with isolated TVIE, those without any complications secondary to IE, and those with IE from HACEK organisms. <xref ref-type="bibr" rid="article-41931.r9">[9]</xref>&#x000a0;For patients with methicillin-sensitive Staph aureus (MSSA) IE, it is vital to change vancomycin to an antibiotic more specific against MSSA. Such antibiotics include nafcillin, oxacillin, or cefazolin. Patient with MRSA IE should be treated with vancomycin for six weeks.</p>
        <p>Surgical treatment of IE is reserved for individuals with the following:&#x000a0;<xref ref-type="bibr" rid="article-41931.r10">[10]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>TV vegetation &#x0003e; 2cm with septic pulmonary emboli.</p>
          </list-item>
          <list-item>
            <p>Persistent bacteremia for one week despite adequate treatment.</p>
          </list-item>
          <list-item>
            <p>Severe tricuspid regurgitation with right-sided heart failure.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-41931.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Infective endocarditis of any form can be difficult to identify. IE can have many nonspecific complaints which can overlap in various autoimmune, infectious, or neoplastic processes. It is important to think of IE as a syndrome. The Duke Modified Criteria serves as the principal diagnostic tool that takes into account all the potential manifestations of this disease process. Some of the differential diagnoses which may also be considered include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Systemic lupus erythematosus</p>
          </list-item>
          <list-item>
            <p>Polymyalgia rheumatic</p>
          </list-item>
          <list-item>
            <p>Lyme Disease</p>
          </list-item>
          <list-item>
            <p>Antiphospholipid syndrome</p>
          </list-item>
          <list-item>
            <p>Libman sacks endocarditis</p>
          </list-item>
          <list-item>
            <p>Atrial myxoma</p>
          </list-item>
          <list-item>
            <p>Rheumatic fever</p>
          </list-item>
          <list-item>
            <p>Marantic endocarditis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-41931.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients with TVIE have good prognosis compared to those with other forms of IE. The fatality rate is lower in these patients. <xref ref-type="bibr" rid="article-41931.r11">[11]</xref>&#x000a0;In one study evaluating native valve endocarditis, overall mortality was 6%. <xref ref-type="bibr" rid="article-41931.r12">[12]</xref> Vegetation size is an important prognostic factor. Those with vegetation greater than 1cm have significantly increased mortality. Individuals who have concurrent left-sided infective endocarditis have a worse prognosis. This&#x000a0;diagnosis is due to the higher risk of abscess development in these cases. <xref ref-type="bibr" rid="article-41931.r1">[1]</xref></p>
      </sec>
      <sec id="article-41931.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of TVIE include <xref ref-type="bibr" rid="article-41931.r13">[13]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Peri-annular abscesses</p>
          </list-item>
          <list-item>
            <p>Septic pulmonary emboli</p>
          </list-item>
          <list-item>
            <p>Splenic abscess</p>
          </list-item>
          <list-item>
            <p>A mycotic aneurysm</p>
          </list-item>
          <list-item>
            <p>Heart failure</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-41931.s11" sec-type="Consultations">
        <title>Consultations</title>
        <p>Infective Endocarditis requires management by a group of physicians. Some physicians who should be involved in the care of these patients include</p>
        <list list-type="bullet">
          <list-item>
            <p>Internal medicine</p>
          </list-item>
          <list-item>
            <p>Infectious disease</p>
          </list-item>
          <list-item>
            <p>Cardiology</p>
          </list-item>
          <list-item>
            <p>Cardiothoracic surgery</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-41931.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be made aware of the potential risk factors for developing TVIE. When hospitalized, efforts should be made to educate these patients about the hazards of IV drug abuse. Furthermore, all available resources should be used to prevent these individuals from relapsing into IVDU again. These include information and access to local rehab centers, education, and pharmacologic options.</p>
      </sec>
      <sec id="article-41931.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>interprofessional management of the patient with IE is essential to ensure positive outcomes. Physicians are important clinicians in assessing these patients and helping establish the diagnosis of TVIE. Nurses involved in the patient's care can identify changes in clinical status or clinical deterioration. Pharmacists have an important role in assisting with antimicrobial management. Some aspects of this care include appropriate empiric regimens, narrowing antimicrobial coverage, and ensuring an adequate therapeutic range of medications and their dosages. Case managers and social workers also play an essential role in finding rehab facilities to help prevent future IVDU, as well as to help arrange for outpatient facilities to obtain longer term IV antibiotics if necessary. Treating TVIE requires a team approach to ensure successful outcomes. The outcomes for patients with TVIE depends on patient age, comorbidity, hemodynamic status, the&#x000a0;presence of sepsis and time of treatment.</p>
      </sec>
      <sec id="article-41931.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=41931&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=41931">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/tricuspid-valve-endocarditis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=41931">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/41931/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=41931">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-41931.s15">
        <fig id="article-41931.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Tricuspid valve IE Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Tricuspid__valve__IE" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-41931.s16">
        <title>References</title>
        <ref id="article-41931.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hussain</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Witten</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shrestha</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Blackstone</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Pettersson</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Tricuspid valve endocarditis.</article-title>
            <source>Ann Cardiothorac Surg</source>
            <year>2017</year>
            <month>May</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>255</fpage>
            <page-range>255-261</page-range>
            <pub-id pub-id-type="pmid">28706868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wurcel</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Chui</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Skinner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Knox</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Snydman</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Stopka</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>ofw157</fpage>
            <pub-id pub-id-type="pmid">27800528</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chambers</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Korzeniowski</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Sande</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1983</year>
            <month>May</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>170</fpage>
            <page-range>170-7</page-range>
            <pub-id pub-id-type="pmid">6843356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fruauff</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Barasch</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Rosenthal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Solitary myeloblastoma presenting as acute hydrocephalus: review of literature, implications for therapy.</article-title>
            <source>Pediatr Radiol</source>
            <year>1988</year>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>369</fpage>
            <page-range>369-72</page-range>
            <pub-id pub-id-type="pmid">3050842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansen</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Jagt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gundtoft</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sorensen</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Pharyngo-oesophageal diverticula. A clinical and cineradiographic follow-up study of 23 cases treated by diverticulectomy.</article-title>
            <source>Scand J Thorac Cardiovasc Surg</source>
            <year>1973</year>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-6</page-range>
            <pub-id pub-id-type="pmid">4632890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dinubile</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Heart block during bacterial endocarditis: a review of the literature and guidelines for surgical intervention.</article-title>
            <source>Am J Med Sci</source>
            <year>1984</year>
            <season>May-Jun</season>
            <volume>287</volume>
            <issue>3</issue>
            <fpage>30</fpage>
            <page-range>30-2</page-range>
            <pub-id pub-id-type="pmid">6731477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Castro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cartoni</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>d'Amati</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Beni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fiorell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gallo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fedele</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pandian</surname>
                <given-names>NG</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic accuracy of transthoracic and multiplane transesophageal echocardiography for valvular perforation in acute infective endocarditis: correlation with anatomic findings.</article-title>
            <source>Clin Infect Dis</source>
            <year>2000</year>
            <month>May</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>825</fpage>
            <page-range>825-6</page-range>
            <pub-id pub-id-type="pmid">10816155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torres-Tortosa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Cueto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vergara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Porto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Guzm&#x000e1;n</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Serrano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Canueto</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de C&#x000e1;diz.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>1994</year>
            <month>Jul</month>
            <volume>13</volume>
            <issue>7</issue>
            <fpage>559</fpage>
            <page-range>559-64</page-range>
            <pub-id pub-id-type="pmid">7805683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gould</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Denning</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Foweraker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Prendergast</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Sandoe</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Spry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Working Party of the British Society for Antimicrobial Chemotherapy</surname>
              </name>
            </person-group>
            <article-title>Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-89</page-range>
            <pub-id pub-id-type="pmid">22086858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Guyton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Skubas</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Sorajja</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sundt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JD</given-names>
              </name>
              <collab>ACC/AHA Task Force Members</collab>
            </person-group>
            <article-title>2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Jun</month>
            <day>10</day>
            <volume>129</volume>
            <issue>23</issue>
            <fpage>2440</fpage>
            <page-range>2440-92</page-range>
            <pub-id pub-id-type="pmid">24589852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ortiz-Bautista</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Granja</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Sevilla</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vilacosta</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sarri&#x000e1;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Olmos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ferrera</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>S&#x000e1;ez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>San Rom&#x000e1;n</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Current profile of infective endocarditis in intravenous drug users: The prognostic relevance of the valves involved.</article-title>
            <source>Int J Cardiol</source>
            <year>2015</year>
            <volume>187</volume>
            <fpage>472</fpage>
            <page-range>472-4</page-range>
            <pub-id pub-id-type="pmid">25846656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;n-D&#x000e1;vila</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Navas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fort&#x000fa;n</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moya</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cobo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pintado</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Quereda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jim&#x000e9;nez-Mena</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Analysis of mortality and risk factors associated with native valve endocarditis in drug users: the importance of vegetation size.</article-title>
            <source>Am Heart J</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>150</volume>
            <issue>5</issue>
            <fpage>1099</fpage>
            <page-range>1099-106</page-range>
            <pub-id pub-id-type="pmid">16291005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-41931.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mocchegiani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nataloni</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Complications of infective endocarditis.</article-title>
            <source>Cardiovasc Hematol Disord Drug Targets</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>240</fpage>
            <page-range>240-8</page-range>
            <pub-id pub-id-type="pmid">19751182</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
